Parotid Gland Cancer disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: PRT009 MIFTS: 34	Parotid Gland Cancer Categories: Cancer diseases, Endocrine diseases, Gastrointestinal diseases, Oral diseases
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Parotid Gland Cancer

MalaCards integrated aliases for Parotid Gland Cancer:

Name: Parotid Gland Cancer ¹² ¹⁵

Parotid Neoplasms ⁴⁵ ⁷⁴

Malignant Neoplasm of the Parotid ¹²

Malignant Tumor of Parotid Gland ¹²

Cancer of Parotid Gland ¹²

Parotid Gland Carcinoma ¹⁷

Cancer of Parotid ⁷⁴

Parotid Neoplasm ¹⁷

Parotid Cancer ¹²

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Oral diseases Gastrointestinal diseases Endocrine diseases

See all MalaCards categories (disease lists)

ICD10: ³⁴

Neoplasms

Malignant neoplasms of lip, oral cavity and pharynx

Malignant neoplasm of parotid gland

External Ids:

Disease Ontology ¹² DOID:9036

ICD9CM ³⁶ 142.0

MeSH ⁴⁵ D010307

NCIt ⁵¹ C3525

SNOMED-CT ⁶⁹ 93949007

ICD10 ³⁴ C07

EFO ¹⁷ EFO_0003873 EFO_1000460

UMLS ⁷⁴ C0030581 C0747273

Sources

Summaries for Parotid Gland Cancer

Disease Ontology : ¹² A salivary gland cancer that is located in the parotid gland.

MalaCards based summary : Parotid Gland Cancer, also known as parotid neoplasms, is related to parotid gland adenoid cystic carcinoma and pleomorphic adenoma carcinoma. An important gene associated with Parotid Gland Cancer is BCYRN1 (Brain Cytoplasmic RNA 1). The drugs Pembrolizumab and Antineoplastic Agents, Immunological have been mentioned in the context of this disorder. Affiliated tissues include salivary gland, skin and lymph node, and related phenotypes are Increased Nanog expression and Increased Nanog expression

Sources

Related Diseases for Parotid Gland Cancer

Diseases related to Parotid Gland Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 21)

#	Related Disease	Score
1	parotid gland adenoid cystic carcinoma	11.2
2	pleomorphic adenoma carcinoma	10.1
3	adenoma	10.0
4	adenocarcinoma	9.9
5	pleomorphic adenoma	9.9
6	acute lymphocytic leukemia	9.9
7	leukemia	9.9
8	lymphocytic leukemia	9.9
9	paroxysmal hemicrania	9.9
10	pilomatrixoma	9.8
11	hyperhidrosis, gustatory	9.8
12	prostate cancer	9.8
13	hemangiopericytoma, malignant	9.8
14	oncocytoma	9.8
15	prostate cancer, hereditary, 8	9.8
16	prostate cancer, hereditary, 6	9.8
17	paraganglioma	9.8
18	lymphangioma	9.8
19	facial paralysis	9.7
20	actinomycosis	9.7
21	mycobacterium abscessus	9.7

Comorbidity relations with Parotid Gland Cancer via Phenotypic Disease Network (PDN):

Facial Paralysis

Graphical network of the top 20 diseases related to Parotid Gland Cancer:

Sources

Symptoms & Phenotypes for Parotid Gland Cancer

GenomeRNAi Phenotypes related to Parotid Gland Cancer according to GeneCards Suite gene sharing:

²⁷

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Increased Nanog expression	GR00371-A-1	9.1	NUP62 ZIC3
2	Increased Nanog expression	GR00371-A-2	9.1	NUP62 ZIC3
3	Increased Nanog expression	GR00371-A-3	9.1	NUP62
4	Increased Nanog expression	GR00371-A-5	9.1	ZIC3

Sources

Drugs & Therapeutics for Parotid Gland Cancer

Drugs for Parotid Gland Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Pembrolizumab

Approved

Phase 2

1374853-91-4

Antineoplastic Agents, Immunological

Phase 2,Phase 1

Bevacizumab

Approved, Investigational

Phase 1

216974-75-3

Synonyms:

216974-75-3

antiVEGF

Anti-VEGF Humanized Monoclonal Antibody

anti-VEGF monoclonal antibody

Anti-VEGF monoclonal antibody

Avastin

Avastin (TN)

bevacizumab

Bevacizumab

Bevacizumab (genetical recombination)

Bevacizumab (genetical recombination) (JAN)

bevacizumab-awwb

D06409

R-435

rhuMAb-VEGF

Cisplatin

Approved

Phase 1

15663-27-1

441203 84093 2767

Synonyms:

(SP-4-1)-diamminedichloridoplatinum

(SP-4-1)-diamminedichloroplatinum

(SP-4-2)-diamminedichloridoplatinum

(SP-4-2)-diamminedichloroplatinum

Abiplatin

Biocisplatinum

Briplatin

CACP

Carboquone

CDDP

CHEBI:35852

CID441203

Cis Pt II

cis-[PtCl2(NH3)2]

cis-DDP

Cis-DDP

Cis-Diaminedichloroplatinum

cis-diamminedichloridoplatinum(II)

cis-Diamminedichloroplatinum

Cis-Diamminedichloroplatinum

cis-diamminedichloroplatinum(II)

cis-Dichlorodiammineplatinum(II)

Cismaplat

Cisplatin

Cisplatine

cisplatino

Cisplatino

Cisplatinum

Cisplatyl

Citoplationo

CPD0-1392

CPDC

CPDD

DB00515

DDP

DDPT

Diamminedichloroplatinum

EU-0100918

Lederplatin

nchembio773-comp1

Neoplatin

Peyrone's chloride

Peyrone's salt

Plastin

Platamine

Platiblastin

Platidiam

Platinex

Platinol

Platinol-AQ

Platinoxan

Platinum Ammine Chloride

Platinum Ammonium Chloride

Platinum Diamine Dichloride

Randa

trans-DDP

Trans-DDP

Trans-Diaminedichloroplatinum

trans-diamminedichloridoplatinum(II)

Trans-Diamminedichloroplatinum

Trans-Dichlorodiammine Platinum

Trans-Platinumdiammine Dichloride

Docetaxel

Approved, Investigational

Phase 1

114977-28-5

148124

Synonyms:

(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate

01885_FLUKA

114977-28-5

4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate

AC1L3WHJ

AC-383

ANX-514

BIND-014

C11231

CHEBI:4672

CHEMBL92

CID148124

D07866

DB01248

docetaxel

Docetaxel

Docetaxel (INN)

docetaxel 114977-28-5

Docetaxel anhydrous

Docetaxel hydrate

Docetaxel trihydrate

Docetaxel, trihydrate

Docetaxel, Trihydrate

Docetaxol

EmDOC

HMS2089K08

InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5

MolPort-003-847-005

nchembio.188-comp8

nchembio.2007.34-comp7

nchembio.573-comp11

nchembio853-comp8

N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel

N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel

N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol

N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol

N-debenzoyl-N-Boc-10-deacetyl taxol

N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol

NSC-628503

PSMA-targeted docetaxel nanoparticle

RP-56976

SDP-014

Taxoltere metro

Taxotere

Taxotere (TN)

Taxotere(R)

TXL

XRP-6976L

Angiogenesis Inhibitors

Phase 1

Protein Kinase Inhibitors

Phase 1

Erlotinib Hydrochloride

Phase 1

183319-69-9

176871

Angiogenesis Modulating Agents

Phase 1

Antimitotic Agents

Phase 1

Sodium Citrate

Approved, Investigational

Not Applicable

68-04-2

Synonyms:

Anhydrous sodium citrate

Anhydrous trisodium citrate

Citric acid, trisodium salt

Natrii citras

Natrocitral

Sodium citrate anhydrous

Sodium citrate, anhydrous

Sodium citrate,anhydrous

trisodium citrate anhydrous

Trisodium citrate, anhydrous

Trisodium-citrate

Citric Acid

Approved, Nutraceutical, Vet_approved

Not Applicable

77-92-9

311

Synonyms:

2-hydroxy-1,2,3-propanetricarboxyic acid

2-Hydroxy-1,2,3-propanetricarboxylate

2-Hydroxy-1,2,3-propanetricarboxylic acid

2-Hydroxytricarballylate

2-Hydroxytricarballylic acid

3-Carboxy-3-hydroxypentane-1,5-dioate

3-carboxy-3-hydroxypentane-1,5-dioic acid

3-Carboxy-3-hydroxypentane-1,5-dioic acid

Acid monohydrate, citric

ácido cítrico

Acidum citricum

Aciletten

Anhydrous citrate

Anhydrous citric acid

beta-Hydroxytricarballylate

beta-Hydroxytricarballylic acid

Chemfill

Citraclean

Citrate

Citretten

Citric acid monoglyceride

Citric acid monohydrate

Citric acid, anhydrous

Citric Acid, Anhydrous

Citric acid,anhydrous

Citro

Citronensaeure

Citronensäure

e 330

e330

H3Cit

Hydrocerol a

Kyselina citronova

Monohydrate, citric acid

Suby g

Uralyt u

uro-Trainer

Calcium

Approved, Nutraceutical

Not Applicable

7440-70-2

271

Synonyms:

Blood coagulation factor XIII

Ca(2+)

Ca2+

Calcio

Calcium

Calcium element

CALCIUM ion

Calcium, doubly charged positive ion

Calcium, elemental

Coagulation factor XIII

Elemental calcium

Factor XIII

Factor XIII a chain

Factor XIII a-chain

Factor XIII transamidase

Factor XIII, coagulation

Fibrin stabilizing factor

Fibrinase

Kalzium

Laki lorand factor

Laki-lorand factor

Stabilizing factor, fibrin

Transamidase, factor XIII

XIII, coagulation factor

Calcium, Dietary

Not Applicable

Anticoagulants

Not Applicable

Citrate

Not Applicable

Chelating Agents

Not Applicable

Interventional clinical trials:

(show all 13)

#	Name	Status	NCT ID	Phase	Drugs
1	Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors	Unknown status	NCT01216800	Phase 3
2	The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome	Completed	NCT01414790	Phase 3
3	Quadrant Versus Superficial Parotidectomy	Withdrawn	NCT01607866	Phase 2, Phase 3
4	Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	Recruiting	NCT02628067	Phase 2
5	Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer	Completed	NCT00405405	Phase 1	Cisplatin;Docetaxel;Bevacizumab;Erlotinib
6	Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors	Unknown status	NCT00534612	Early Phase 1
7	Feasibility Study of MRI Imaging on Parotid Gland Stimulation	Unknown status	NCT02294838	Not Applicable
8	Optical Detection of Peripheral Nerve Bundles During Surgery	Completed	NCT01731379
9	Retrospective Clinical Outcome of Parotid Tumor Surgery	Completed	NCT01983176
10	Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors	Completed	NCT02527226	Not Applicable
11	Complications in Parotid Surgery	Completed	NCT02486393
12	Multiparametric Magnetic Resonance Imaging Versus Fine Needle Aspiration Cytology for Parotid Gland Neoplasms	Recruiting	NCT03849482
13	Intra-parotid Facial Nerve Imaging in Parotidectomy	Recruiting	NCT03822728	Not Applicable

Search NIH Clinical Center for Parotid Gland Cancer

Cochrane evidence based reviews: parotid neoplasms

Sources

Genetic Tests for Parotid Gland Cancer

Sources

Anatomical Context for Parotid Gland Cancer

MalaCards organs/tissues related to Parotid Gland Cancer:

⁴²

Salivary Gland, Skin, Lymph Node, Colon

The Foundational Model of Anatomy Ontology organs/tissues related to Parotid Gland Cancer:

²⁰

The Parotid Gl

Sources

Publications for Parotid Gland Cancer

Articles related to Parotid Gland Cancer:

(show top 50) (show all 57)

#	Title	Authors	Year
1	Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness. ( 30732953 )	Park W...Jeong HS	2019
2	Comparing the RTOG/EORTC and LENT-SOMA scoring systems for the evaluation of late skin toxicity after<sup>125</sup>I seed brachytherapy for parotid gland cancer. ( 29406124 )	Mao M.H....Zhang J.G.	2018
3	Comparing the RTOG/EORTC and LENT-SOMA scoring systems for the evaluation of late skin toxicity after (125)I seed brachytherapy for parotid gland cancer. ( 28495444 )	Mao M.H....Han Z.X.	2017
4	Prognostic relevance of epithelial-mesenchymal transition and proliferation in surgically treated primary parotid gland cancer. ( 27729431 )	Busch A....Stenner M.	2016
5	Prediction of outcome by lymph node ratio in patients with parotid gland cancer. ( 27185037 )	Meyer M.F....Beutner D.	2016
6	Surgery for Primary Malignant Parotid Neoplasms. ( 27093700 )	Deschler DG...Eisele DW	2016
7	Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience. ( 26203086 )	Chang J.W....Choi E.C.	2015
8	Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity. ( 26053092 )	GrA1newald I....Stenner M.	2015
9	Use of fine-needle aspiration cytology in the diagnosis of parotid neoplasms. ( 25424665 )	Henrys CE...Grigg R	2015
10	Diagnostic investigation of parotid neoplasms: a 16-year experience of freehand fine needle aspiration cytology and ultrasound-guided core needle biopsy. ( 25457828 )	Haldar S...Howlett D	2015
11	Paediatric parotid neoplasms: a 10 year retrospective imaging and pathology review of these rare tumours. ( 25515793 )	Mamlouk MD...Glastonbury CM	2015
12	Incidental Parotid Neoplasms: Pathology and Prevalence. ( 26019135 )	Britt CJ...Hartig GK	2015
13	Retrospective Assessment of the Utility of Imaging, Fine-Needle Aspiration Biopsy, and Intraoperative Frozen Section in the Management of Parotid Neoplasms: The Weill Cornell Medical College Experience. ( 26159894 )	Patel KR...Cohen MA	2015
14	Re: Use of fine-needle aspiration cytology in the diagnosis of parotid neoplasms. ( 26498567 )	Weerasinghe A...Foong MM	2015
15	Facial nerve reconstruction following radical parotidectomy and subtotal petrosectomy for advanced malignant parotid neoplasms. ( 26981471 )	S?nchez-Burgos R...Garc?a MB	2015
16	The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy : Incidence of radioepidermitis and the dose-response relationship. ( 25200358 )	Mao M.H....Shi Y.	2014
17	An exploratory study of long-term health-related quality of life in patients with surgically treated primary parotid gland cancer. ( 25223976 )	Stenner M....HA1ttenbrink K.B.	2014
18	Diagnostic value of CT perfusion imaging for parotid neoplasms. ( 24186883 )	Dong Y...Wei FC	2014
19	Robotically assisted selective neck dissection in parotid gland cancer: preliminary report. ( 23208780 )	Kim C.H....Koh Y.W.	2013
20	Occurrence of lymph node metastasis in early-stage parotid gland cancer. ( 21671057 )	Stenner M....Huettenbrink K.B.	2012
21	Prognostic value of proliferating cell nuclear antigen in parotid gland cancer. ( 21874325 )	Stenner M....Klussmann J.P.	2012
22	Preliminary results of (125)I interstitial brachytherapy for locally recurrent parotid gland cancer in previously irradiated patients. ( 22488812 )	Zheng L....Yu G.	2012
23	Sonoelastography techniques in the evaluation and diagnosis of parotid neoplasms. ( 22367472 )	Westerland O...Howlett D	2012
24	Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypes. ( 21397494 )	Stenner M....Klussmann J.P.	2011
25	An overview of the rare parotid gland cancer. ( 21917153 )	Ho K....Yen Y.	2011
26	Discrimination of parotid neoplasms from the normal parotid gland by use of Raman spectroscopy and support vector machine. ( 21439894 )	Yan B...Li LJ	2011
27	Synchronous unilateral parotid neoplasms. A case report. ( 19179956 )	Herce-L?pez J...P?rez-S?nchez JM	2009
28	Parotid neoplasms: analysis of 600 patients attended at a single institution. ( 19784416 )	Takahama Junior A...Kowalski LP	2009
29	Gastrointestinal: isolated colonic metastasis from parotid gland cancer. ( 18699984 )	Fu K....Tsujinaka Y.	2008
30	An ileal metastasis from a parotid gland cancer that mimicked a flat adenoma. ( 17285507 )	Fu K.I....Kaji Y.	2007
31	Massive deep lobe parotid neoplasms and parapharyngeal space-occupying lesions: contemporary diagnostics and surgical approaches. ( 17921922 )	Popovski V	2007
32	Preoperative cytology in the management of parotid neoplasms. ( 16500471 )	Aversa S...Conticello S	2006
33	Integrin receptors and extracellular matrix components in parotid neoplasms. ( 15812349 )	Charalabopoulos K...Batistatou A	2005
34	Use of cross-sectional imaging in predicting surgical location of parotid neoplasms. ( 15891497 )	Divi V...Mukherji SK	2005
35	Genetic expression profiling of parotid neoplasms by cDNA microarrays. ( 16450770 )	Pastore A...Pelucchi S	2005
36	Parotid gland cancer: a case report of a primitive adenocarcinoma arising from a multirecurrent pleomorphic adenoma. ( 15149165 )	Izzo L....Caputo M.	2004
37	We present our experience employing magnetic resonance imaging (MRI) for the preoperative assessment of the patients with parotid gland cancer. ( 15366759 )	Narozny W....Mikaszewski B.	2004
38	Use of cross-sectional imaging in predicting facial nerve sacrifice during surgery for parotid neoplasms. ( 15583440 )	Divi V...Teknos TN	2004
39	Patients' perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. ( 12956917 )	Marshall AH...Bradley PJ	2003
40	Parotid neoplasms in children: experience of diagnosis and management in a district general hospital. ( 14505619 )	Ethunandan M...Pratt C	2003
41	Parotid neoplasms: diagnosis, treatment, and intraparotid facial nerve anatomy. ( 12080993 )	Tsai SC...Hsu HT	2002
42	Synchronous occurrence of 2 histologically distinct parotid neoplasms. ( 10847294 )	Godden DR...Warren A	2000
43	Synchronous unilateral parotid neoplasms of different histological types. ( 10383249 )	Stavrianos SD...Soames JV	1999
44	Society of Surgical Oncology Practice Guidelines. Parotid gland cancer surgical practice guidelines. ( 9268982 )		1997
45	Bilateral parotid neoplasms. ( 7822187 )	Myers EN...Suen JY	1994
46	Subtotal petrosectomy in the management of advanced parotid neoplasms. ( 8464641 )	Leonetti JP...Hartman JM	1993
47	Prognostic variables in parotid gland cancer. ( 1747227 )	Frankenthaler R.A....Goepfert H.	1991
48	Synchronous unilateral parotid neoplasms of different histologic types. ( 2542187 )	Schilling JA...Speigel JC	1989
49	Amylase expression in human parotid neoplasms: evidence by in situ hybridization for lack of transcription of the amylase gene. ( 2451689 )	Morley DJ...Hodes ME	1988
50	ABO (H) cell surface antigens in benign and malignant parotid neoplasms. ( 6314050 )	Woltering EA...Sharma HM	1983

Sources

Genes for Parotid Gland Cancer

Genes related to Parotid Gland Cancer (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	BCYRN1	Brain Cytoplasmic RNA 1	RNA Gene	150	Experimental evidence: Regulation ⁴⁰	9422992
2	NUP62	Nucleoporin 62	Protein Coding	15.64	DISEASES inferred ¹⁵
3	SERPINB6	Serpin Family B Member 6	Protein Coding	15.33	DISEASES inferred ¹⁵
4	ZIC3	Zic Family Member 3	Protein Coding	14.57	DISEASES inferred ¹⁵
5	FLCN	Folliculin	Protein Coding	14.39	DISEASES inferred ¹⁵
6	ANKRD11	Ankyrin Repeat Domain 11	Protein Coding	14.38	DISEASES inferred ¹⁵

Sources

Variations for Parotid Gland Cancer

Sources

Expression for Parotid Gland Cancer

Search GEO for disease gene expression data for Parotid Gland Cancer.

Sources

Pathways for Parotid Gland Cancer

Sources

GO Terms for Parotid Gland Cancer

Biological processes related to Parotid Gland Cancer according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	in utero embryonic development	GO:0001701	8.62	ANKRD11 FLCN

Sources

Sources for Parotid Gland Cancer

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia